MARKET

CNCR

CNCR

Range Cancer Therapeutics ETF
NASDAQ
15.82
+0.56
+3.67%
After Hours: 15.82 +0.1 +0.64% 16:00 07/26 EDT
OPEN
15.91
PREV CLOSE
15.26
HIGH
15.91
LOW
15.54
VOLUME
3.88K
TURNOVER
0
52 WEEK HIGH
17.96
52 WEEK LOW
9.22
TOTAL ASSET
14.29M
YTD YIELD
20.47%
1D
5D
1M
3M
1Y
5Y
1D
Time for Healthcare ETFs?
NASDAQ · 3d ago
Weekly Report: what happened at CNCR last week (0715-0719)?
Weekly Report · 4d ago
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week. These are the top performingETFs by a one-week and a four-week average. The bottom performing fund are the bottom performing by a four week average. TSLA-relatedETFs were among the top-performing ETFs for the week.
Seeking Alpha · 07/17 17:38
ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors
Seeking Alpha · 07/17 08:42
5 Top ETFs of Last Week
NASDAQ · 07/15 12:00
Weekly Report: what happened at CNCR last week (0708-0712)?
Weekly Report · 07/15 10:37
Weekly Report: what happened at CNCR last week (0701-0705)?
Weekly Report · 07/08 10:38
CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened
Seeking Alpha · 07/04 02:30
More
Profile
Fund Name
Range Cancer Therapeutics ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper